Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure
- PMID: 10758967
- DOI: 10.1016/s0735-1097(00)00531-3
Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure
Abstract
Objectives: To create a valid, sensitive, disease-specific health status measure for patients with congestive heart failure (CHF).
Background: Quantifying health status is becoming increasingly important for CHF. The Kansas City Cardiomyopathy Questionnaire (KCCQ) is a new, self-administered, 23-item questionnaire that quantifies physical limitations, symptoms, self-efficacy, social interference and quality of life.
Methods: To establish the performance characteristics of the KCCQ, two distinct patient cohorts were recruited: 70 stable and 59 decompensated CHF patients with ejection fractions of <40. Upon entry into the study, patients were administered the KCCQ, the Minnesota Living with Heart Failure Questionnaire and the Short Form-36 (SF-36). Questionnaires were repeated three months later.
Results: Convergent validity of each KCCQ domain was documented by comparison with available criterion standards (r = 0.46 to 0.74; p < 0.001 for all). Among those with stable CHF who remained stable by predefined criteria (n = 39), minimal changes in KCCQ domains were detected over three months of observation (mean change = 0.8 to 4.0 points, p = NS for all). In contrast, large changes in score were observed among patients whose decompensated CHF improved three months later (n = 39; mean change = 15.4 to 40.4 points, p < 0.01 for all). The sensitivity of the KCCQwas substantially greater than that of the Minnesota Living with Heart Failure and the SF-36 questionnaires.
Conclusions: The KCCQis a valid, reliable and responsive health status measure for patients with CHF and may serve as a clinically meaningful outcome in cardiovascular research, patient management and quality assessment.
Similar articles
-
Psychometric properties of the Japanese version of the Kansas City Cardiomyopathy Questionnaire in Japanese patients with chronic heart failure.Health Qual Life Outcomes. 2020 Jul 17;18(1):236. doi: 10.1186/s12955-020-01483-0. Health Qual Life Outcomes. 2020. PMID: 32680513 Free PMC article.
-
Comparing Measures to Assess Health-Related Quality of Life in Heart Failure With Preserved Ejection Fraction.JACC Heart Fail. 2018 Jul;6(7):552-560. doi: 10.1016/j.jchf.2018.02.006. Epub 2018 Jun 6. JACC Heart Fail. 2018. PMID: 29885952 Free PMC article.
-
Psychometric properties of a Swedish version of the Kansas City Cardiomyopathy Questionnaire in a Chronic Heart Failure population.Eur J Cardiovasc Nurs. 2008 Sep;7(3):214-21. doi: 10.1016/j.ejcnurse.2007.08.005. Epub 2007 Dec 3. Eur J Cardiovasc Nurs. 2008. PMID: 18060843
-
Assessing health-related quality of life in patients with heart failure: a systematic, standardized comparison of available measures.Heart Fail Rev. 2014 May;19(3):359-67. doi: 10.1007/s10741-013-9394-7. Heart Fail Rev. 2014. PMID: 23681849 Review.
-
Disease-specific health-related quality of life questionnaires for heart failure: a systematic review with meta-analyses.Qual Life Res. 2009 Feb;18(1):71-85. doi: 10.1007/s11136-008-9416-4. Epub 2008 Dec 4. Qual Life Res. 2009. PMID: 19052916 Review.
Cited by
-
Effects of dapagliflozin and empagliflozin on 6-min walk distance in heart failure with preserved and reduced ejection fraction: A systematic review and meta-analysis of randomized controlled trials involving 2624 patients.Eur J Clin Pharmacol. 2024 Mar 18. doi: 10.1007/s00228-024-03660-2. Online ahead of print. Eur J Clin Pharmacol. 2024. PMID: 38498097 Review.
-
Percutaneous Left Ventricular Unloading During High-Risk Coronary Intervention: Rationale and Design of the CHIP-BCIS3 Randomized Controlled Trial.Circ Cardiovasc Interv. 2024 Mar;17(3):e013367. doi: 10.1161/CIRCINTERVENTIONS.123.013367. Epub 2024 Feb 27. Circ Cardiovasc Interv. 2024. PMID: 38410944 Free PMC article. Clinical Trial.
-
The Finkelstein-Schoenfeld Test: A Note on Some Overlooked Issues Concerning Power.Ther Innov Regul Sci. 2024 Feb 5. doi: 10.1007/s43441-023-00608-z. Online ahead of print. Ther Innov Regul Sci. 2024. PMID: 38316728
-
Translation, Cultural Adaptation, Validation and Reliability of Persian Left Ventricular Dysfunction-36 Questionnaire.Arch Iran Med. 2023 Oct 1;26(10):575-581. doi: 10.34172/aim.2023.84. Arch Iran Med. 2023. PMID: 38310414 Free PMC article.
-
Diastolic Dysfunction and Health Status Outcomes After Transcatheter Aortic Valve Replacement.Struct Heart. 2023 Sep 27;8(1):100225. doi: 10.1016/j.shj.2023.100225. eCollection 2024 Jan. Struct Heart. 2023. PMID: 38283566 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
